Bone loss in patients with PA may be reversed by MR antagonists or adrenal surgery.<h4>Conclusions</h4>PA may be a secondary cause of osteoporosis and is associated with an increased risk of bone fracture. Here, NR3C2 is linked to osteoporosis.